Neuropsychiatric disorders have complex causes and exhibit considerable individual variability as they develop over time. This suggests the need for a shift from a focus on observable clinical symptoms to a personalized trajectory monitoring…
Continue Reading
Cognitive symptoms are prevalent across neuropsychiatric disorders, increase distress and impair quality of life. Self-guided digital interventions offer accessibility, scalability, and may overcome the research-to-practice treatment gap. Seventy-six trials with 5214 participants were identified….
Continue Reading
The healthcare unit of South Korean diversified conglomerate Lotte has teamed up with iMediSync to co-develop new AI-driven healthcare services.Based on a press release, the two companies signed a memorandum of understanding to cooperate…
Continue Reading
Brain stimulation (BStim) encompasses multiple modalities (e.g., deep brain stimulation, responsive neurostimulation) that utilize electrodes implanted in deep brain structures to treat neurological disorders. Currently, BStim is primarily used to treat movement disorders such…
Continue Reading
What You Should Know:– PsychoGenics Inc., a provider of AI-enabled phenotypic drug discovery and preclinical CRO services launches eCube®, a novel pharmaco-electroencephalography (“pharmacoEEG”) platform.The platform supports phenotypic drug discovery, which unlike traditional target-based drug…
Continue Reading
